Hospital & Health Care - , Kuala Lumpur, Malaysia
MGRC was founded in 2004 and listed on the ACE Market of Bursa Malaysia Securities in 2010. As a leading genomics and biopharmaceutical company inSoutheast Asia, we have pioneered genome sequencing, bioinformaticsanalysis, genetic screening services, and cancer immunotherapies in the region.We have an established track record of delivering on large-scale projects for the Government of Malaysia, as well as local and international research centres, public institutes, academia and corporations from pharmaceutical and various other sectors. Some notable customers have includedNovartis, Brigham & Women's Hospital (of Harvard Medical School) and Washington University of Medicine, among many others.Our extensive experience in healthcare, especially in genomics, geneticsand clinical diagnostics extends to translational medicine, which is thetransferring of knowledge and technology from research domainsto clinical use by doctors in clinics and hospitals.With our high-throughput sequencing lab, advanced microarray facility andnew state-of-the-art cell processing lab, we are committed to continuallyproviding improved access to the latest immunotherapy and healthcaresolutions for our customers.